CRISPR Therapeutics所有資訊

CRISPR Therapeutics | 4：持股變動聲明-高管 Kulkarni Samarth

04/17 17:50 (美東)

CRISPR Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Capital International Investors(10.2%)

04/10 12:02 (美東)

CRISPR Therapeutics | 4：持股變動聲明-高管 KASINGER JAMES R.

03/22 17:48 (美東)

CRISPR Therapeutics | 4：持股變動聲明-高管 Prasad Raju

03/22 17:48 (美東)

CRISPR Therapeutics | 4：持股變動聲明-高管 Kulkarni Samarth

03/22 17:48 (美東)

CRISPR Therapeutics | 4：持股變動聲明-高管 Kulkarni Samarth

03/18 17:46 (美東)

CRISPR Therapeutics | 4：持股變動聲明-高管 Prasad Raju

03/18 17:46 (美東)

CRISPR Therapeutics | 4：持股變動聲明-高管 KASINGER JAMES R.

03/12 17:49 (美東)

CRISPR Therapeutics | 4：持股變動聲明-高管 Kulkarni Samarth

03/12 17:49 (美東)

CRISPR Therapeutics | 4：持股變動聲明-董事 George Simeon

02/27 18:42 (美東)

CRISPR Therapeutics | 4：持股變動聲明-高管 KASINGER JAMES R.

02/21 17:52 (美東)

CRISPR Therapeutics | 4：持股變動聲明-高管 Kulkarni Samarth

02/21 17:52 (美東)

CRISPR Therapeutics | 4：持股變動聲明-高管 Kulkarni Samarth

02/16 17:47 (美東)

CRISPR Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Nikko Asset Management Americas, Inc.(4.24%)

02/12 18:25 (美東)

CRISPR Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Capital International Investors(8.1%)

02/09 18:06 (美東)

CRISPR Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Sumitomo Mitsui Trust Holdings, Inc. (“SMTH”)(4.24%),Nikko Asset Management Co., Ltd. (“NAM”)(4.24%)

02/05 06:12 (美東)

CRISPR Therapeutics | 4：持股變動聲明-高管 Kulkarni Samarth

01/31 17:49 (美東)

CRISPR Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-ARK Investment Management LLC(10.75%)

01/29 16:07 (美東)

CRISPR Therapeutics | 4：持股變動聲明-高管 Kulkarni Samarth

01/18 00:00 (美東)

CRISPR Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-ARK Investment Management LLC(10.75%)

01/10 00:00 (美東)